Search results
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 12 hours agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...
Stock Market Today: Dow rides broadening out of rally to notch 4th weekly win By Investing.com
Investing.com· 1 day agoInvesting.com-- The Dow closed higher Friday to clinch its fourth-weekly win as the broadening out...
Merit Financial Group LLC Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 2 days agoMerit Financial Group LLC lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.1% in the 4th quarter, according to its most recent 13F filing with the SEC ...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 1 day agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 5 hours agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 11 hours agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Dow Jones Today: Stocks Mixed As Dow on Track To Extend Winning Streak to Eight Consecutive Sessions
Investopedia· 8 hours agoModerna (MRNA) slid 4% as the biotech’s effort to move beyond just a COVID-19 vaccine was stalled...
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick...
Benzinga via Yahoo Finance· 6 hours agoEditor’s note: This story has been updated to correct an error in the price action of Charter...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 14 hours agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...